Related content

Duloxetine appears to be efficacious in patients with mild, moderate or severe major depressive disorder

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Augmentation of Citalopram with Aspirin for Treating Major Depressive Disorder, a Double Blind Randomized Placebo Controlled Clinical Trial

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 2, 2014-08 ,pp. : 108-111

Bentham Science Publishers

Access to resources Recommend Favorite

Omega-3 fatty acids in major depressive disorder - A preliminary double-blind, placebo-controlled trial

By Su K.-P.   Huang S.-Y.   Chiu C.-C.   Shen W.W.  

European Neuropsychopharmacology, Vol. 13, Iss. 4, 2003-08 ,pp. : 267-271

Elsevier

Access to resources Recommend Favorite

Duloxetine: a guide to its use in major depressive disorder

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 3, 2008-03 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

By Mancini Michele   Perna Giampaolo   Rossi Andrea   Petralia Antonino  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1167-1181

Informa Healthcare

Access to resources Recommend Favorite